CR10221A - A SOLID COMPOSITION OF LIOFILIZED TAXANE, A PROCEDURE TO PREPARE SUCH SOLID COMPOSITION, A PHARMACEUTICAL FORMULATION AND A FORMULATION ASSEMBLY (KIT) - Google Patents
A SOLID COMPOSITION OF LIOFILIZED TAXANE, A PROCEDURE TO PREPARE SUCH SOLID COMPOSITION, A PHARMACEUTICAL FORMULATION AND A FORMULATION ASSEMBLY (KIT)Info
- Publication number
- CR10221A CR10221A CR10221A CR10221A CR10221A CR 10221 A CR10221 A CR 10221A CR 10221 A CR10221 A CR 10221A CR 10221 A CR10221 A CR 10221A CR 10221 A CR10221 A CR 10221A
- Authority
- CR
- Costa Rica
- Prior art keywords
- solid composition
- taxane
- formulation
- liofilized
- kit
- Prior art date
Links
- 239000008247 solid mixture Substances 0.000 title abstract 4
- 229940123237 Taxane Drugs 0.000 title abstract 3
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000003960 organic solvent Substances 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 abstract 1
- 229930012538 Paclitaxel Natural products 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 239000004359 castor oil Substances 0.000 abstract 1
- 235000019438 castor oil Nutrition 0.000 abstract 1
- 229960003668 docetaxel Drugs 0.000 abstract 1
- 238000004108 freeze drying Methods 0.000 abstract 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 abstract 1
- 229960001592 paclitaxel Drugs 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 abstract 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 abstract 1
- 229920000053 polysorbate 80 Polymers 0.000 abstract 1
- 229940068968 polysorbate 80 Drugs 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Una composición sólida de taxano (preferentemente docetaxel y paclitaxel) liofílizada, apta para preparar formulaciones farmacéuticas para mamíferos, en particular humanos, que comprende dicho taxano, tensoactivo, excipiente de liofílización y ácido; y además es esencialmente libre de solvente orgánico. Donde dicha composición sólida es libre de polisorbato 80 y de aceite de castor polioxietilado; es estéril; es soluble en soluciones acuosas en ausencia de solvente orgánico; y tiene una densidad aparente de entre 0,05 g/mlA solid composition of lyophilized taxane (preferably docetaxel and paclitaxel), suitable for preparing pharmaceutical formulations for mammals, in particular humans, comprising said taxane, surfactant, lyophilization excipient and acid; and it is also essentially free of organic solvent. Where said solid composition is free of polysorbate 80 and polyoxyethylated castor oil; it is sterile; it is soluble in aqueous solutions in the absence of organic solvent; and has an apparent density of between 0.05 g / ml
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ARP066100208 | 2006-01-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR10221A true CR10221A (en) | 2008-11-07 |
Family
ID=50831838
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR10221A CR10221A (en) | 2006-01-20 | 2008-08-20 | A SOLID COMPOSITION OF LIOFILIZED TAXANE, A PROCEDURE TO PREPARE SUCH SOLID COMPOSITION, A PHARMACEUTICAL FORMULATION AND A FORMULATION ASSEMBLY (KIT) |
| CR10222A CR10222A (en) | 2006-01-20 | 2008-08-20 | A PHARMACEUTICAL FORMULATION OF TAXANO, A SOLID COMPOSITION OF TAXANO, A PROCEDURE FOR THE PREPARATION OF SUCH SOLID COMPOSITION OF TAXANO, A SOLUBILIZING COMPOSITION OF SUCH SOLID COMPOSITION OF TAXANO, AND A SET OF .... |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR10222A CR10222A (en) | 2006-01-20 | 2008-08-20 | A PHARMACEUTICAL FORMULATION OF TAXANO, A SOLID COMPOSITION OF TAXANO, A PROCEDURE FOR THE PREPARATION OF SUCH SOLID COMPOSITION OF TAXANO, A SOLUBILIZING COMPOSITION OF SUCH SOLID COMPOSITION OF TAXANO, AND A SET OF .... |
Country Status (2)
| Country | Link |
|---|---|
| CR (2) | CR10221A (en) |
| UA (1) | UA94085C2 (en) |
-
2007
- 2007-01-18 UA UAA200810530A patent/UA94085C2/en unknown
-
2008
- 2008-08-20 CR CR10221A patent/CR10221A/en not_active Application Discontinuation
- 2008-08-20 CR CR10222A patent/CR10222A/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CR10222A (en) | 2008-11-07 |
| UA94085C2 (en) | 2011-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY30099A1 (en) | A SOLID COMPOSITION OF LIOFILIZED TAXANE, A PROCEDURE TO PREPARE SUCH SOLID COMPOSITION, A PHARMACEUTICAL FORMULATION AND A SET (KIT) FOR THE PREPARATION OF AN INJECTABLE TAXAN FORMULATION | |
| ES2524458T3 (en) | DNase for the treatment of male subfertility | |
| ES2721148T3 (en) | Pharmaceutical compositions of paclitaxel, paclitaxel analogues or paclitaxel conjugates and related methods of preparation and use | |
| BRPI0615292A8 (en) | compositions and methods for preparing poorly soluble water drugs with increased stability | |
| AR073123A1 (en) | PHARMACEUTICAL COMPOSITION INCLUDING A SUBSTANTIALLY AMORFO TAXANE TO BE USED IN THE TREATMENT OF NEOPLASIC DISEASE | |
| ECSP088951A (en) | / STABLE PHARMACEUTICAL COMPOSITION CONTAINING DOCETAXEL AND METHOD FOR MANUFACTURING | |
| SV2004001556A (en) | ACID PREPARATIONS OF INSULIN WITH IMPROVED STABILITY | |
| CL2010000188A1 (en) | A method for treating an infection in a subject comprising the administration of 9 - [(2,2-dimethyl-propylamino) -methyl] -minocycline or a salt thereof; pharmaceutical composition comprising said compound; and its use. | |
| BRPI0714399B8 (en) | oral liquid pharmaceutical composition | |
| AR048878A1 (en) | TOPIC COMPOSITIONS OF METADONA AND METHODS FOR USE | |
| AR067347A1 (en) | ANTIHELMINTIC COMBINATION | |
| UY29410A1 (en) | PHARMACEUTICAL COMPOSITIONS BASED ON METHODAMIDES OF ACID 4- (4 - / - 3 (-4-CHLORO-3-TRIFLUOROMETIFENIL) UREIDO) FENOXI) PIRIDIN-2-CARBOXYLIC, PREPARATION PROCEDURE AND APPLICATIONS. | |
| AR059350A1 (en) | PHARMACEUTICAL FORMULATION FOR AEROSOLS WITH TWO OR MORE ACTIVE PRINCIPLES AND AT LEAST A TENSIOACTIVE SUBSTANCE | |
| MX2009010289A (en) | COMPOSITIONS FOR NASAL ADMINISTRATION. | |
| FI964285A0 (en) | Pharmaceutical preparations based on derivatives belonging to the taxane class | |
| AR049063A1 (en) | POSACONAZOL INJECTABLE PHARMACEUTICAL COMPOSITIONS WITH STABILIZED PARTICLES | |
| ES2554245T3 (en) | Injectable parasiticidal formulations of levamisole and macrocyclic lactones | |
| BRPI0513673A (en) | method for increasing the efficacy and transport of enterally administered biologically active compounds, a vehicle used for enteral administration of biologically active compounds, a pharmaceutical composition and the use of an effective amount of one or more phosphate derivatives | |
| AR054238A1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING A BIGUANIDA AND A DERIVATIVE OF TIAZOLIDINDIONA | |
| WO2007124700A3 (en) | Pharmaceutical composition containing taxane derivative destined for the preparation of an infusion solution, method of preparation thereof and use thereof | |
| AR045911A1 (en) | SELF-EMULSIONABLE FORMULATIONS AND SELF-MICROEMULSIONABLE FORMULATIONS FOR ORAL ADMINISTRATION OF TAXOIDS | |
| SE0302924D0 (en) | Pharmaceutical composition having a cationic excipient | |
| CR10221A (en) | A SOLID COMPOSITION OF LIOFILIZED TAXANE, A PROCEDURE TO PREPARE SUCH SOLID COMPOSITION, A PHARMACEUTICAL FORMULATION AND A FORMULATION ASSEMBLY (KIT) | |
| ECSP109871A (en) | ORAL PHARMACEUTICAL SOLUTIONS CONTAINING TELBIVUDINE | |
| AR061364A1 (en) | PHARMACEUTICAL COMPOSITION FOR PARENTERAL ADMINISTRATION AS A VACCINE CONTAINING AN ANTI-IDIOTIC ANTI-CA MONOCLONAL ANTIBODY -125 AND ALUMINUM, AND PROCESS FOR THE PREPARATION OF A COMPOSITION |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal (granting procedure) |